Asploro Journal of Biomedical and Clinical Case Reports
![Asploro Journal of Biomedical and Clinical Case Reports [ISSN: 2582-0370]](https://i0.wp.com/asploro.com/wp-content/uploads/2023/11/Asploro-Journal-of-Biomedical-and-Clinical-Case-Reports-2024.jpg?resize=853%2C1024&ssl=1)
ISSN: 2582-0370
Article Type: Case Report
DOI: 10.36502/2024/ASJBCCR.6342
Asp Biomed Clin Case Rep. 2024 Apr 12;7(2):88-93
Atsuko Kawahito1, Hiroshi Bando1,2,3iD*, Yoshinobu Kato1, Hisako Yamashita1, Yoshikane Kato1
1Kanaiso Hospital, Tokushima, Japan
2Japan low carbohydrate diet promotion association (JLCDPA), Kyoto, Japan
3Medical Research/Tokushima University, Tokushima, Japan
Corresponding Author: Hiroshi Bando ORCID iD
Address: Tokushima University /Medical Research, Nakashowa 1-61, Tokushima 770-0943, Japan.
Received date: 28 February 2024; Accepted date: 05 April 2024; Published date: 12 April 2024
Citation: Kawahito A, Bando H, Kato Y, Yamashita H, Kato Y. Beneficial Recognition of Glucose Variability for Adequate Lifestyle by Continuous Glucose Monitoring (CGM). Asp Biomed Clin Case Rep. 2024 Apr 12;7(2):88-93.
Copyright © 2024 Kawahito A, Bando H, Kato Y, Yamashita H, Kato Y. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
Keywords: Continuous Glucose Monitoring (CGM), Freestyle Libre, Multiple Daily Insulin (MDI), Low Carbohydrate Diet (LCD), Time in Range (TIR)
Abbreviations: CGM: Continuous Glucose Monitoring; MDI: Multiple Daily Insulin; LCD: Low Carbohydrate Diet; TIR: Time in Range
Abstract
Recently, actual changes in blood glucose can be measured by continuous glucose monitoring (CGM) using FreeStyle Libre. The case involves a 67-year-old male patient with type 2 diabetes (T2D) treated with Multiple Daily Insulin (MDI) therapy, who underwent CGM. Analysis of the CGM data revealed that hyperglycemia resulted from increased carbohydrate intake and irregular meal timings and quantities. The estimated HbA1c from CGM was 6.6%, whereas the HbA1c value recorded at the outpatient clinic during the same period was 7.3%. The use of CGM applications encourages diabetic patients to be mindful of their carbohydrate intake in daily life, leading to an increased ratio of time spent in the target range (TIR).
